These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1719372)

  • 1. Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (Tyr-527).
    Cobb BS; Payne DM; Reynolds AB; Parsons JT
    Mol Cell Biol; 1991 Dec; 11(12):5832-8. PubMed ID: 1719372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR; Brodeur SR; Shalloway D; Laudano AP
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
    Sabe H; Okada M; Nakagawa H; Hanafusa H
    Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527.
    Harvey R; Hehir KM; Smith AE; Cheng SH
    Mol Cell Biol; 1989 Sep; 9(9):3647-56. PubMed ID: 2476663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of a pp60c-src-related tyrosine kinase that effectively phosphorylates a synthetic peptide derived from p34cdc2.
    Litwin CM; Cheng HC; Wang JH
    J Biol Chem; 1991 Feb; 266(4):2557-66. PubMed ID: 1703531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry of the Src protein-tyrosine kinase: regulation by SH2 and SH3 domains.
    Liu X; Pawson T
    Recent Prog Horm Res; 1994; 49():149-60. PubMed ID: 7511826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Kmiecik TE; Shalloway D
    Cell; 1987 Apr; 49(1):65-73. PubMed ID: 3103925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.
    O'Brien MC; Fukui Y; Hanafusa H
    Mol Cell Biol; 1990 Jun; 10(6):2855-62. PubMed ID: 2111444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.
    Cooper JA; King CS
    Mol Cell Biol; 1986 Dec; 6(12):4467-77. PubMed ID: 2432403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristylation is required for Tyr-527 dephosphorylation and activation of pp60c-src in mitosis.
    Bagrodia S; Taylor SJ; Shalloway D
    Mol Cell Biol; 1993 Mar; 13(3):1464-70. PubMed ID: 7680096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.
    Reynolds AB; Vila J; Lansing TJ; Potts WM; Weber MJ; Parsons JT
    EMBO J; 1987 Aug; 6(8):2359-64. PubMed ID: 2822389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.
    Bjorge JD; Bellagamba C; Cheng HC; Tanaka A; Wang JH; Fujita DJ
    J Biol Chem; 1995 Oct; 270(41):24222-8. PubMed ID: 7592628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and biochemical properties of the c-src+ gene product overexpressed in chicken embryo fibroblasts.
    Levy JB; Brugge JS
    Mol Cell Biol; 1989 Aug; 9(8):3332-41. PubMed ID: 2477684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.